Newsgroups Main » Newsgroups Directory » Food, Drink and Drugs » Drugs
Miscellaneous (rec.drugs.misc)
From gnosis@brahman.nullnet.fi (JaniPoijärvi) Thu Apr 20 21:59:41 1995
Path: uunet!bounce-back
From: gnosis@brahman.nullnet.fi (Jani "Gnosis" Poijärvi)
Newsgroups: news.announce.newgroups,news.groups,alt.drugs,alt.drugs.caffeine,alt.drugs.chemistry,alt.drugs.culture,alt.drugs.hard,alt.drugs.pot,alt.drugs.psychedelics,alt.hemp,alt.psychoactives,talk.politics.drugs
Subject: RFD: rec.drugs.{cannabis,misc}
Followup-To: news.groups
Date: 20 Apr 1995 15:13:31 -0400
Organization: Brahman, Helsinki, Finland
Lines: 181
Sender: tale@uunet.uu.net
Approved: tale@uunet.uu.net
Message-ID: <3n6bor$lu6@rodan.UU.NET>
NNTP-Posting-Host: rodan.uu.net
Xref: gs2.UU.NET news.announce.newgroups:6669 news.groups:145565 alt.drugs:134647 alt.drugs.caffeine:6969 alt.drugs.chemistry:3143 alt.drugs.culture:2789 alt.drugs.hard:1378 alt.drugs.pot:14940 alt.drugs.psychedelics:6148 alt.hemp:18291 alt.psychoactives:10540 talk.politics.drugs:39103
REQUEST FOR DISCUSSION (RFD)
unmoderated group rec.drugs.cannabis
unmoderated group rec.drugs.misc
Newsgroups : rec.drugs.cannabis
rec.drugs.misc
Status : Both groups unmoderated
Distribution : World-wide
Proponents : A. J. Moss <ajm1007@phx.cam.ac.uk>
Jani Poijärvi <gnosis@brahman.nullnet.fi>
Mentor : Bill Godfrey <godfrey2@coventry.ac.uk>
Posted to : alt.drugs.* news.announce.newgroups
alt.hemp news.groups
alt.psychoactives talk.politics.drugs
This RFD is being issued in accordance with the guidelines set in the
"How to create a new Usenet newsgroup" FAQ that is regularly posted to
news.announce.newgroups. Its language is based on previously submitted
RFDs.
Discussion of this proposal should take place in news.groups and
talk.politics.drugs. Please keep proposals concerning this RFD in
news.groups, and take debates about the merits of legalisation or the
morality of drug-taking to talk.politics.drugs.
This is *not* a call for votes. Assuming the discussion goes smoothly,
a Call For Votes (CFV) will be posted by an independent third party 21
to 30 days from the date of this posting.
SUMMARIES
~~~~~~~~~
rec.drugs.cannabis Discussion of the drug cannabis (marijuana).
rec.drugs.misc General discussion of all recreational drugs.
RATIONALE
~~~~~~~~~
In brief, over the last year alt.drugs.* has become such a chaotic mess
that it is practically unusable, and we believe that the creation of
rec.drugs is the only workable solution.
A bit of history. alt.drugs has been operating since 1986, and roughly a
year ago the traffic finally reached such intolerable levels that a number
of subgroups were spawned off. Unfortunately, the groups were created
before consensus was reached, and hence many of the groups, such as
alt.drugs.pot which is meaningless to most people outside the US, were
poorly thought out. The groups were promptly rmgrouped by the alt.config
regulars, but it was decided that creating a new set of groups would be
even worse and several sets of booster newgroups were issued.
alt.drugs.pot and alt.drugs.psychedelics soon started to generate loads
of traffic, but due to the low propagation of the new groups almost
everything was, and still is, crossposted to alt.drugs. And of course
the many people whose sites did not receive the subgroups still kept
on posting to alt.drugs. Hence, the cure was worse than the problem;
someone interested in cannabis now has to read both alt.drugs _and_
alt.drugs.pot to catch all the cannabis-related traffic, or at least
crosspost their messages to both groups to catch all readers.
Some selected USENET Arbitron May 1995 [Snowhare] statistics:
Group Readers Propagation Messages Crossposting
alt.drugs 207816 60% 5450 17%
alt.drugs.pot 44346 32% 3682 36%
alt.drugs.caffeine 41157 48% 391 36%
alt.drugs.psychedelics 35071 31% 1793 37%
alt.drugs.chemistry 29854 32% 595 49%
alt.drugs.culture 19709 32% 821 57%
alt.drugs.hard ? < 20% ? > 50%
Since the Tom Servo mess, it has become even more difficult to create
usable alt groups, such as alt.drugs.hard which has abysmal propagation
despite clear need. A set of junk groups have also been created without
any discussion whatsoever (alt.drugs.pot.cultivation, alt.hemp.recreational,
alt.hemp.politics, etc) and they only serve to clutter up the hierarchy
and confuse newbies.
Parallels will most likely drawn to alt.sex, the logical counterpart of
alt.drugs in terms of history and controversial nature. However, the
analogy is not exact, since alt.sex was split up long before alt.drugs
and crossposting in alt.sex is hence far less endemic.
We are thus proposing that the two most active alt.drugs.* groups,
alt.drugs itself and alt.drugs.pot, be moved over to the rec hierarchy.
Other groups may follow later. The rec hierarchy has been selected because
these groups are specifically for recreational drugs, and placement in the
talk or misc hierarchies would lead to messages about medical drugs as well.
A second-level name has been chosen since drugs cannot be justifiably
placed under any existing category.
CHARTERS
~~~~~~~~
Attempts to sell or trade controlled substances in either group are *not*
permissible. Discussion of the merits of legalization and the morality of
using drugs is off topic and should be conducted in talk.politics.drugs.
rec.drugs.cannabis
~~~~~~~~~~~~~~~~~~
A newsgroup dedicated to the recreational use of cannabis. Possible topics
include: descriptions of effects; comparisons with other drugs; advice
concerning the experience (e.g. what music to listen to); paraphernalia
(e.g. bongs), home-made and commercial; syntheses, extractions and recipes.
rec.drugs.misc
~~~~~~~~~~~~~~
This group is similar in scope to rec.drugs.cannabis, but the discussion
concerns drugs which do not have their own subgroup within rec.drugs.
Due to the existence of alt.drugs.caffeine, caffeine is an acceptable
subject for this group, but posts which fall within the charter of
rec.food.drink.coffee or similar groups are discouraged.
Since alcohol and nicotine have their own groups outside the alt.drugs
hierarchy (rec.food.drink and alt.smoking, respectively), posts regarding
the two substances are discouraged.
CONSEQUENCES FOR THE AFFECTED ALT GROUPS
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Once the rec.drugs groups are created, there will be massive cross-posting
between them and the old alt groups until the new groups are widely
supported. We propose the following schedule to handle the situation:
1. Once rec.drugs passes, periodic reminders (once a week) will be posted
automatically to alt.drugs, using the "Expires:" header.
2. After about 2 months, rec.drugs will be generally available and most of
the alt.drugs regulars will have moved. An auto-responder will be set
up to reply to every alt.drugs post, asking the poster to move to rec.drugs;
this will also help discourage cross-posting between the two groups.
3. After 6 months, assuming negligible traffic remains, alt.drugs.* will be
rmgrouped by as many alt.config regulars as possible.
EXPECTED ARGUMENTS AGAINST REC.DRUGS
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
In the hope of preventing needless arguments, we would like to take a
moment to present the case against some fallacious arguments against
the groups that are likely to arise.
* "Drugs are illegal and hence cannot be discussed"
The Internet is a global community and laws vary greatly. For example, the
Netherlands have decriminalized cannabis, and the United States allows the
use of the hallucinogen mescaline in the religious ceremonies of the Native
American Church. And of course, purely theoretical discussion about any
subject is permissible.
* "Use of drugs is morally wrong"
The issue at stake here is whether there _is_ a need for the rec.drugs
groups, not whether there _should_ be one. Given the popularity of
alt.drugs, we think that there is a clear need. If you must discuss
morality, please take it to talk.politics.drugs.
* "Creation of rec.drugs would lead to bad publicity for the 'Net"
To the unscrupulous reporter in search of a scoop or the uneducated reader
of an article, it makes little difference whether the group is named
"alt.drugs" or "rec.drugs".
* "A Big 7 group would legitimize illegal drug abuse"
Saying that rec.drugs would legitimize drug abuse is like claiming that
talk.rape legitimizes rape. Both groups deal with subjects that, although
distasteful to many, exist and should not be ignored.
FUTURE CALL FOR VOTES
~~~~~~~~~~~~~~~~~~~~~
After a discussion period of 21 to 30 days, if there are no overwhelming
objections to the proposed groups, there will be a Call For Votes (CFV)
posted to the same groups as this RFD. The voting period will be at least
21 days. If the group passes by a 2/3 majority and receives 100 more YES
votes than NO votes, it will be created.
--
Jani "Gnosis" Poijärvi On the neverending quest /(o\ BRAHMAN
gnosis@brahman.nullnet.fi for knowledge by identity. \o)/ +358-0-498797
From ajm1007@cus.cam.ac.uk Wed May 3 19:17:37 1995
Path: uunet!bounce-back
From: ajm1007@cus.cam.ac.uk (A.J. Moss)
Newsgroups: news.announce.newgroups,news.groups,alt.drugs,alt.drugs.caffeine,alt.drugs.chemistry,alt.drugs.culture,alt.drugs.hard,alt.drugs.pot,alt.drugs.psychedelics,alt.hemp,alt.psychoactives,talk.politics.drugs
Subject: 2nd RFD: rec.drugs.{cannabis,misc,psychedelic}
Followup-To: news.groups
Date: 3 May 1995 15:30:18 -0400
Organization: University of Cambridge, England
Lines: 336
Sender: tale@uunet.uu.net
Approved: tale@uunet.uu.net
Message-ID: <3o8lka$san@rodan.UU.NET>
NNTP-Posting-Host: rodan.uu.net
Xref: gs2.UU.NET news.announce.newgroups:6756 news.groups:147426 alt.drugs:136756 alt.drugs.caffeine:7091 alt.drugs.chemistry:3360 alt.drugs.culture:3090 alt.drugs.hard:1511 alt.drugs.pot:16163 alt.drugs.psychedelics:6617 alt.hemp:18894 alt.psychoactives:10682 talk.politics.drugs:39737
REQUEST FOR DISCUSSION (RFD)
unmoderated group rec.drugs.cannabis
unmoderated group rec.drugs.misc
unmoderated group rec.drugs.psychedelic
Proponents : A. J. Moss <ajm1007@cus.cam.ac.uk>
Jani Poijarvi <gnosis@brahman.nullnet.fi>
Mentor : Bill Godfrey <godfrey2@coventry.ac.uk>
Posted to : alt.drugs.* news.announce.newgroups
alt.hemp news.groups
alt.psychoactives talk.politics.drugs
This RFD is being issued in accordance with the guidelines set in the
"How to create a new Usenet newsgroup" FAQ that is regularly posted to
news.announce.newgroups. Its language is based on previously submitted
RFDs.
This is *not* a call for votes. Assuming the discussion goes smoothly,
a Call For Votes (CFV) will be posted by an independent third party 21
to 30 days after the posting of the original RFD.
IMPORTANT
~~~~~~~~~
Most discussion of this proposal should take place in news.groups.
However, general political discussion (about topics such as the merits
of legalisation or the morality of drug-taking) is a completely separate
issue, which is off topic in news.groups. Please confine such debates to
talk.politics.drugs, and keep the two topics separate.
CHANGES TO THE RFD
~~~~~~~~~~~~~~~~~~
1. rec.drugs.psychedelic has been added to the list of proposed groups.
2. Its charter, and that of rec.drugs.misc, spell out the difference
between these two groups.
3. The reasons for creating the new groups have been clarified somewhat,
in response to requests on news.groups.
4. The rationale behind the proposed hierarchy structure is now explained
in depth.
5. The proposed method for phasing out alt.drugs.* has been improved, and
is now stated explicitly.
6. The section, "Expected arguments against rec.drugs" and a one paragraph
comparison with alt.sex have been removed.
In summary, about 90% of this RFD has been rewritten to make it all clearer,
but the only changes to its substance fall under (1) and (5).
SUMMARIES
~~~~~~~~~
rec.drugs.cannabis The drug cannabis (marijuana).
rec.drugs.misc Stimulants, sedatives, smart drugs et al.
rec.drugs.psychedelic LSD, Ecstasy, magic mushrooms and the like.
RATIONALE FOR MOVING TO REC
~~~~~~~~~~~~~~~~~~~~~~~~~~~
rec.drugs is being proposed because the alt.drugs hierarchy is in such a
mess that last year's split has become worse than useless, and there is no
prospect of matters improving while the groups remain within alt.
A bit of history: alt.drugs, created in 1987, is one of the oldest alt
groups. Its traffic has grown steadily; roughly a year ago it reached such
intolerable levels that a number of subgroups were spawned off.
Unfortunately, the groups were created before a consensus was reached about
them, and many of them (such as alt.drugs.pot, which is meaningless to most
people outside the US) were poorly thought out. They were promptly
rmgrouped by the alt.config regulars, but it was decided that creating a
new set of groups would be even worse, so several sets of booster newgroups
were issued, recreating the hierarchy.
Some selected USENET Arbitron May 1995 [Snowhare] statistics:
Group Readers Propagation Messages Crossposting
~~~~~ ~~~~~~~ ~~~~~~~~~~~ ~~~~~~~~ ~~~~~~~~~~~~
alt.drugs 207816 60% 5450 17%
alt.drugs.pot 44346 32% 3682 36%
alt.drugs.caffeine 41157 48% 391 36%
alt.drugs.psychedelics 35071 31% 1793 37%
alt.drugs.chemistry 29854 32% 595 49%
alt.drugs.culture 19709 32% 821 57%
alt.drugs.hard ? < 20% ? > 50%
When alt.drugs was created, newgroups were honoured by every site that
carried the alt hierarchy; its propagation is still very high for an alt
group. In contrast, by the time the alt.drugs subgroups were proposed, alt
had become very large and disorganised, full of frivolous groups. Newgroup
messages are now treated with some skepticism by many admins, and the
alt.drugs subgroups were created in such a messy way that they enjoy
barely half the propagation of their parent group.
alt.drugs.pot and alt.drugs.psychedelics soon started to generate lots of
traffic, but due to the low propagation of the new groups, almost everything
was, and still is, crossposted to the parent group. And of course, the many
people whose sites do not receive the subgroups still keep on posting to
alt.drugs. Other people, in persevering with the hierarchy and declining to
crosspost everything, make matters even worse. The cure was worse than the
problem: anyone interested in cannabis now has to read both alt.drugs _and_
alt.drugs.pot to catch all the cannabis-related traffic, or at least
crosspost their messages to both groups to catch all readers.
In recent months, Tom Servo (a user at Netcom) has repeatedly posted a
guide to sending the control messages needed to create new groups. Sadly,
his guide makes no mention of Usenet naming conventions or the alt.config
discussion process, which has since led to hundreds of useless and/or
illegally named alt groups being created. It is now much harder to get a
useful group created and widely accepted.
This has been the fate of alt.drugs.hard: it was proposed to address a
clear need, but it has been crippled by its abysmal propagation. What's
more, a number of junk groups have been created without any discussion
whatsoever (e.g. alt.drugs.pot.cultivation, alt.hemp.recreational,
alt.hemp.politics), and they serve only to clutter up the hierarchy and
confuse newbies.
It has long been known that alt groups are almost impossible to destroy;
this recent experience shows that they can be equally difficult to create.
Any steps taken to improve matters are doomed to failure unless they are
widely honoured, and alt is in such a state that there is no hope of this
happening unless the entire drugs hierarchy is moved to the big 8.
Furthermore, the proposed drugs groups in the big 8 are likely to have
identical propagation, which will eliminate the biggest current pressure
to crosspost between them.
The proposed groups are being placed in rec because they are specifically
for recreational drugs; placement in soc, talk or misc would lead to a
greater proportion of off-topic posts. A second-level name has been
chosen because drugs cannot justifiably be placed under any existing
category.
RATIONALE FOR THE HIERARCHY STRUCTURE
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The initial set of rec.drugs.* groups will resemble the three most active
alt.drugs.* groups: alt.drugs, alt.drugs.pot and alt.drugs.psychedelics.
Their charters will be mutually exclusive to a large extent; unlike
alt.drugs, rec.drugs.misc will not be a general dumping ground for every
topic. A fair number of people are likely to subscribe to r.d.cannabis
and/or r.d.psychedelic without joining r.d.misc.
The intention is that the three groups will have (1) roughly equal traffic
levels, and (2) very little crossposting.
The recent Arbitron statistics (see above) show that (1) is plausible.
The proportion of the total alt.drugs.* traffic carried by each group,
discounting the effects of crossposting, was:
alt.drugs 42%
alt.drugs.pot 29%
alt.drugs.psychedelics 14%
rec.drugs.cannabis will be identical to alt.drugs.pot, which has about
the right traffic level at the moment.
rec.drugs.misc will be a bit like alt.drugs without the crossposting,
which will reduce its traffic a fair amount.
rec.drugs.psychedelic will cover a number of popular drugs, such as LSD
and MDMA (Ecstasy). As long as the charter makes this clear, the group's
bandwidth will be fairly high.
(2) will depend on how well the group charters are drawn up. r.d.cannabis
is straightforward, but there is no really simple definition of a
psychedelic. Alexander Shulgin, the world's foremost authority in this
field, defines this word as, "pertaining to a change in the normal state of
consciousness, usually with some accompanying changes in the acuity of the
senses." However, a newbie could conceivably argue that this definition
applies equally well to _any_ recreational drug.
I've based the group charters on the directory structure of the drugs
archive at hyperreal.com. If a drug appears in the /drugs/psychedelics
directory, it belongs in rec.drugs.psychedelic. A pre-existing structure
like this will help resolve borderline cases, when a drug could conceivably
fit into either .psychedelic or .misc. As I said above, MDMA and its
relatives will also appear in r.d.psychedelic, in part to balance out the
levels of traffic between the three newsgroups.
The proposed summary lines are rather terse, but are aimed to guide posts
to the right group within the hierarchy. They will obviously be updated if
the groups are split.
The proposed hierarchy is about as small as it can possibly be, and it will
inevitably grow in the near future. Some people will want it to be bigger
now. However, calls for further groups will tend to be speculative at this
point, and it's less trouble to create new subgroups later than to delete
ones that turn out to be unpopular. There will also be fewer teething
problems associated with the move if the hierarchy is small to begin with.
Six months or so after the initial groups' creation, we can take stock of
the rec.drugs hierarchy, and be in a much better position to know which
further groups are needed.
POLITICS ON REC.DRUGS
~~~~~~~~~~~~~~~~~~~~~
The illegal status of most recreational drugs generates a lot of political
discussion on alt.drugs, which will clearly be off topic in the rec.drugs
groups. On the other hand, many political developments are important enough
that they need to be brought to everyone's attention; a request not to
crosspost them to rec.drugs will simply be ignored. As things currently
stand, they will probably be crossposted to every rec.drugs group.
The group charters ask everyone to be vigilant in excluding political
material, by not posting it to rec.drugs.* without good reason and by
setting follow-ups to talk.politics.drugs. Other than that, there are no
proposals to deal with it; at least, not yet. This is for the same reason
that I advocate starting off with a small hierarchy -- once the rec.drugs
hierarchy is established and we know the scale of the problem, we'll be
in a much better position to deal with it.
The consensus on news.groups has come down firmly against moderating these
groups. While discussion may wander off topic from time to time, moderation
is an unnecessarily heavy-handed way of dealing with it. Also, the groups'
subject matter is something that arouses strong feelings in some people;
setting up the means to censor them is felt to be completely unacceptable.
CHARTERS
~~~~~~~~
All three groups
~~~~~~~~~~~~~~~~
Attempts to sell or trade controlled substances here are *NOT* permissible.
Remember that the authorities are likely to be watching these newsgroups.
Political discussion is strongly discouraged. Please do not post it here
unless it's really important. And if you do post or reply to anything of
a political nature here, please make sure you set follow-ups to
talk.politics.drugs.
Because of the way the rec.drugs hierarchy is divided, the scope of each
group, and the topics discussed there, will be broadly similar. The main
distinction between them is that they will be discussing different classes
of drugs.
rec.drugs.cannabis
~~~~~~~~~~~~~~~~~~
A newsgroup dedicated to the recreational use of cannabis. Possible topics
include: descriptions of effects; comparisons with other drugs; advice
concerning the experience (e.g. what music to listen to); paraphernalia
(e.g. bongs), home-made and commercial; syntheses, extractions and recipes.
rec.drugs.psychedelic
~~~~~~~~~~~~~~~~~~~~~
Discussion here concerns the following drugs, and anything with a similar
effect (the list is by no means complete):
Psychedelics: LSD, psilocybin, DMT, 2CB.
Plants and fungi: mushrooms, morning glory seeds, cacti.
Dissociatives: PCP, ketamine, dextromethorphan, Jimson weed.
Empathogens: MDMA (Ecstasy), and its close relatives MDA and MDEA.
As a basic rule, if the drug appears in the /drugs/psychedelics or
/drugs/mdma directories at hyperreal.com, it belongs in this group.
Cannabis, which has its own group, is specifically excluded.
Discussion about many aspects of drug culture (e.g. trippy computer programs,
or iconoclasts such as Timothy Leary) will find a natural home here.
rec.drugs.misc
~~~~~~~~~~~~~~
This group is devoted to drugs which do not have their own subgroup
within rec.drugs. At present, examples of such drugs are:
Opiates
Stimulants (cocaine, amphetamines, methcathinone)
Depressants (barbiturates, benzodiazapines (e.g. Valium))
Inhalants (nitrous oxide)
Nootropics (smart drugs)
Prozac
This list, which is not intended to be complete, will shorten if and when
a separate newsgroup is created for some of these drugs.
However, rec.drugs.misc is *not* a general discussion ground for all drugs.
Discussions about drugs which have their own rec.drugs newsgroup should not
take place here under normal circumstances.
Caffeine, alcohol and tobacco already have their own forums in certain alt
groups and in the rec.food.drink hierarchy. Posts that are on topic there
are unlikely to be relevant here.
MECHANICS OF THE MOVE FROM ALT.DRUGS.*
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Unlike with big 8 groups, there is no automatic method for moving alt
groups and redirecting their traffic. Also, most people scan for groups
alphabetically, so alt.drugs.* will continue to have a steady trickle of
newcomers throughout the move. We need to make sure that everyone stops
using alt.drugs.* once the rec.drugs hierarchy is created.
The following procedure will handle this. The relevant newsgroups' weekly
FAQs will explain what's happening and ask everyone to cooperate.
1. As soon as the new groups are created, everything will deliberately be
crossposted between the two drugs hierarchies. Once we get this working,
people will be able to unsubscribe from alt.drugs.*. Since not every site
will receive and honour the newgroups at once, it won't be possible to stop
posting to alt.drugs.* immediately.
2. A month or two later, rec.drugs.* will propagate widely and be in
general use. We'll then agree on a date on which we'll stop crossposting
to alt.drugs.*. Provided enough people know what is happening, alt.drugs.*
traffic will fall immediately, making it easier to tell everyone else
what's going on.
The groups' summary lines will be changed to reflect the developments:
e.g. "alt.drugs Use the rec.drugs hierarchy instead."
3. After another month (or sooner if the move goes really smoothly), an
auto-responder will be set up to reply to every post to alt.drugs.*, asking
the poster to move to rec.drugs. This will also catch crossposts between
the two hierarchies.
4. alt.drugs.* will be rmgrouped by an alt.config regular as soon its
traffic becomes negligible. It will never entirely die out by itself --
as mentioned above, newbies will subscribe to the first promising group
they find, which will tend to be alt.drugs rather than rec.drugs.
5. Inevitably, some sites won't honour the rmgroup, or someone will try
to recreate the groups. alt.drugs is the kind of group that is especially
likely to become an "orphan", with a few hapless readers at sites where it
still exists. To help these people, periodic (fortnightly or monthly)
reminders will continue to be posted to alt.drugs.* after the rmgroup.
They'll be crossposted to alt.answers, partly to guarantee their
propagation.
FUTURE CALL FOR VOTES
~~~~~~~~~~~~~~~~~~~~~
After a discussion period of 21 to 30 days, if there are no overwhelming
objections to the proposed groups, there will be a Call For Votes (CFV)
posted to the same groups as this RFD. The voting period will be at least
21 days. If the group passes by a 2/3 majority and receives 100 more YES
votes than NO votes, it will be created.
--
"A little learning is a dangerous thing; /-----------------------\
Drink deep, or taste not the Pierian spring: | A.J. Moss |
There shallow draughts intoxicate the brain, | ajm1007@cus.cam.ac.uk |
And drinking largely sobers us again." \-----------------------/
From warren@syra.net Thu Jun 8 17:18:42 1995
Status: RO
Path: uunet!bounce-back
From: warren@syra.net (Warren Lavallee)
Newsgroups: news.announce.newgroups,news.groups,alt.drugs,alt.drugs.caffeine,alt.drugs.chemistry,alt.drugs.culture,alt.drugs.hard,alt.drugs.pot,alt.drugs.psychedelics,alt.hemp,alt.psychoactives,talk.politics.drugs,alt.recovery.na
Subject: CFV: rec.drugs.{cannabis,psychedelic,misc}
Followup-To: poster
Date: 8 Jun 1995 17:17:07 -0400
Organization: Usenet Volunteer Votetakers
Lines: 329
Sender: tale@uunet.uu.net
Approved: tale@uunet.uu.net
Expires: 30 Jun 1995 00:00:00 GMT
Message-ID: <rec.drugs-CFV1@uunet.uu.net>
References: <3o8lka$san@rodan.UU.NET>
Reply-To: voting@syra.net
NNTP-Posting-Host: rodan.uu.net
Xref: gs2.UU.NET news.announce.newgroups:7029 news.groups:152919 alt.drugs:141832 alt.drugs.caffeine:7359 alt.drugs.chemistry:3965 alt.drugs.culture:3751 alt.drugs.hard:1700 alt.drugs.pot:19043 alt.drugs.psychedelics:7786 alt.hemp:20486 alt.psychoactives:11059 talk.politics.drugs:41630 alt.recovery.na:1539
FIRST CALL FOR VOTES (of 2)
unmoderated group rec.drugs.cannabis
unmoderated group rec.drugs.psychedelic
unmoderated group rec.drugs.misc
Newsgroups line:
rec.drugs.cannabis The drug cannabis (marijuana).
rec.drugs.psychedelic LSD, Ecstasy, magic mushrooms and the like.
rec.drugs.misc Stimulants, sedatives, smart drugs et al.
Votes must be received by 23:59:59 UTC, 29 June 1995.
This vote is being conducted by a neutral third party. For voting
questions only contact Warren Lavallee <warren@Syra.NET>. For
questions about the proposed group contact Jani Poijrvi
<gnosis@brahman.nullnet.fi>.
RATIONALE
~~~~~~~~~
In brief, over the last year alt.drugs.* has become such a chaotic mess
that it is practically unusable, and we believe that the creation of
rec.drugs is the only workable solution. We are thus proposing that the
three most active alt.drugs.* groups, alt.drugs itself, alt.drugs.pot
and alt.drugs.psychedelics be moved over to the rec hierarchy.
rec.drugs is being proposed because the alt.drugs hierarchy is in such a
mess that last year's split has become worse than useless, and there is no
prospect of matters improving while the groups remain within alt.
A bit of history: alt.drugs, created in 1987, is one of the oldest alt
groups. Its traffic has grown steadily; roughly a year ago it reached such
intolerable levels that a number of subgroups were spawned off.
Unfortunately, the groups were created before a consensus was reached about
them, and many of them (such as alt.drugs.pot, which is meaningless to most
people outside the US) were poorly thought out. They were promptly
rmgrouped by the alt.config regulars, but it was decided that creating a
new set of groups would be even worse, so several sets of booster newgroups
were issued, recreating the hierarchy.
Some selected USENET Arbitron May 1995 [Snowhare] statistics:
Group Readers Propagation Messages Crossposting
~~~~~ ~~~~~~~ ~~~~~~~~~~~ ~~~~~~~~ ~~~~~~~~~~~~
alt.drugs 207816 60% 5450 17%
alt.drugs.pot 44346 32% 3682 36%
alt.drugs.caffeine 41157 48% 391 36%
alt.drugs.psychedelics 35071 31% 1793 37%
alt.drugs.chemistry 29854 32% 595 49%
alt.drugs.culture 19709 32% 821 57%
alt.drugs.hard ? < 20% ? > 50%
When alt.drugs was created, newgroups were honoured by every site that
carried the alt hierarchy; its propagation is still very high for an alt
group. In contrast, by the time the alt.drugs subgroups were proposed, alt
had become very large and disorganised, full of frivolous groups. Newgroup
messages are now treated with some skepticism by many admins, and the
alt.drugs subgroups were created in such a messy way that they enjoy
barely half the propagation of their parent group.
alt.drugs.pot and alt.drugs.psychedelics soon started to generate lots of
traffic, but due to the low propagation of the new groups, almost everything
was, and still is, crossposted to the parent group. And of course, the many
people whose sites do not receive the subgroups still keep on posting to
alt.drugs. Other people, in persevering with the hierarchy and declining to
crosspost everything, make matters even worse. The cure was worse than the
problem: anyone interested in cannabis now has to read both alt.drugs _and_
alt.drugs.pot to catch all the cannabis-related traffic, or at least
crosspost their messages to both groups to catch all readers.
In recent months, Tom Servo (a user at Netcom) has repeatedly posted a
guide to sending the control messages needed to create new groups. Sadly,
his guide makes no mention of Usenet naming conventions or the alt.config
discussion process, which has since led to hundreds of useless and/or
illegally named alt groups being created. It is now much harder to get a
useful group created and widely accepted.
This has been the fate of alt.drugs.hard: it was proposed to address a
clear need, but it has been crippled by its abysmal propagation. What's
more, a number of junk groups have been created without any discussion
whatsoever (e.g. alt.drugs.pot.cultivation, alt.hemp.recreational,
alt.hemp.politics), and they serve only to clutter up the hierarchy and
confuse newbies.
It has long been known that alt groups are almost impossible to destroy;
this recent experience shows that they can be equally difficult to create.
Any steps taken to improve matters are doomed to failure unless they are
widely honoured, and alt is in such a state that there is no hope of this
happening unless the entire drugs hierarchy is moved to the big 8.
Furthermore, the proposed drugs groups in the big 8 are likely to have
identical propagation, which will eliminate the biggest current pressure
to crosspost between them.
The proposed groups are being placed in rec because they are specifically
for recreational drugs; placement in soc, talk or misc would lead to a
greater proportion of off-topic posts. A second-level name has been
chosen because drugs cannot justifiably be placed under any existing
category.
RATIONALE FOR THE HIERARCHY STRUCTURE
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The initial set of rec.drugs.* groups will resemble the three most active
alt.drugs.* groups: alt.drugs, alt.drugs.pot and alt.drugs.psychedelics.
Their charters will be mutually exclusive to a large extent; unlike
alt.drugs, rec.drugs.misc will not be a general dumping ground for every
topic. A fair number of people are likely to subscribe to r.d.cannabis
and/or r.d.psychedelic without joining r.d.misc.
The intention is that the three groups will have (1) roughly equal traffic
levels, and (2) very little crossposting.
The recent Arbitron statistics (see above) show that (1) is plausible.
The proportion of the total alt.drugs.* traffic carried by each group,
discounting the effects of crossposting, was:
alt.drugs 42%
alt.drugs.pot 29%
alt.drugs.psychedelics 14%
rec.drugs.cannabis will be identical to alt.drugs.pot, which has about
the right traffic level at the moment.
rec.drugs.misc will be a bit like alt.drugs without the crossposting,
which will reduce its traffic a fair amount.
rec.drugs.psychedelic will cover a number of popular drugs, such as LSD
and MDMA (Ecstasy). As long as the charter makes this clear, the group's
bandwidth will be fairly high.
(2) will depend on how well the group charters are drawn up. r.d.cannabis
is straightforward, but there is no really simple definition of a
psychedelic. Alexander Shulgin, the world's foremost authority in this
field, defines this word as, "pertaining to a change in the normal state of
consciousness, usually with some accompanying changes in the acuity of the
senses." However, a newbie could conceivably argue that this definition
applies equally well to _any_ recreational drug.
I've based the group charters on the directory structure of the drugs
archive at hyperreal.com. If a drug appears in the /drugs/psychedelics
directory, it belongs in rec.drugs.psychedelic. A pre-existing structure
like this will help resolve borderline cases, when a drug could conceivably
fit into either .psychedelic or .misc. As I said above, MDMA and its
relatives will also appear in r.d.psychedelic, in part to balance out the
levels of traffic between the three newsgroups.
The proposed summary lines are rather terse, but are aimed to guide posts
to the right group within the hierarchy. They will obviously be updated if
the groups are split.
The proposed hierarchy is about as small as it can possibly be, and it will
inevitably grow in the near future. Some people will want it to be bigger
now. However, calls for further groups will tend to be speculative at this
point, and it's less trouble to create new subgroups later than to delete
ones that turn out to be unpopular. There will also be fewer teething
problems associated with the move if the hierarchy is small to begin with.
Six months or so after the initial groups' creation, we can take stock of
the rec.drugs hierarchy, and be in a much better position to know which
further groups are needed.
CHARTER
All three groups
~~~~~~~~~~~~~~~~
Attempts to sell or trade controlled substances here are *NOT*
permissible. Remember that the authorities are likely to be watching
these newsgroups.
Political discussion is strongly discouraged. Please do not post it here
unless it's really important. And if you do post or reply to anything of
a political nature here, please make sure you set follow-ups to
talk.politics.drugs.
Because of the way the rec.drugs hierarchy is divided, the scope of each
group, and the topics discussed there, will be broadly similar. The
main distinction between them is that they will be discussing different
classes of drugs.
The groups are intended to divide up the total rec.drugs traffic in a
sensible way; please be sure to post to the correct one. If your site
receives any one of these groups, it should really receive all of them.
rec.drugs.cannabis
~~~~~~~~~~~~~~~~~~
A newsgroup dedicated to the recreational use of cannabis. Possible
topics include: descriptions of effects; comparisons with other drugs;
advice concerning the experience (e.g. what music to listen to);
paraphernalia (e.g. bongs), home-made and commercial; syntheses,
extractions and recipes.
The following topics are of peripheral relevance to this newsgroup. They
may, at a pinch, be discussed here, but should not make up too much of
the newsgroup's traffic.
Medical uses of cannabis: e.g. the treatment of glaucoma and AIDS
wasting syndrome; countering the toxic side-effects of chemotherapy
(cancer-treating drugs). The suitability or otherwise of alternatives to
cannabis.
Industrial uses of the cannabis plant: e.g. paper, cotton, rope;
hydrocarbons for fuel or plastics. Economic and environmental
considerations. Historical and possible future uses.
rec.drugs.psychedelic
~~~~~~~~~~~~~~~~~~~~~
The psychedelics promise to provide a unique insight into the workings
of the human mind. Set and setting are all-important, which explains the
varying success different researchers have had with them. Their current
legal status, and many of the horror stories concerning them, are based
more in politics than in fact. They are reasonably safe if treated with
respect.
Discussion here concerns the following drugs, and anything with a
similar effect (the list is by no means complete):
Psychedelics: LSD, psilocybin, DMT, 2CB.
Plants and fungi: mushrooms, morning glory seeds, cacti.
Dissociatives: PCP, ketamine, dextromethorphan, Jimson weed.
Empathogens: MDMA (Ecstasy), and its close relatives MDA and MDEA.
As a basic rule, if the drug appears in the /drugs/psychedelics or
/drugs/mdma directories at hyperreal.com, it belongs in this group.
Discussion about many aspects of drug culture (e.g. trippy computer
programs, or iconoclasts such as Timothy Leary) will find a natural home
here.
rec.drugs.misc
~~~~~~~~~~~~~~
This group is devoted to drugs which do not have their own subgroup
within rec.drugs. At present, examples of such drugs are:
Opiates
Stimulants (cocaine, amphetamines, methcathinone)
Depressants (barbiturates, benzodiazapines (e.g. Valium))
Inhalants (nitrous oxide)
Nootropics (smart drugs)
Prozac
This list, which is not intended to be complete, will shorten if and when
a separate newsgroup is created for any of these drugs.
However, rec.drugs.misc is *not* a general discussion ground for all
drugs. Discussions about drugs which have their own rec.drugs newsgroup
should not take place here under normal circumstances.
Caffeine, alcohol and tobacco already have their own fora in the
alt.smoking and rec.food.drink hierarchies. The effects of the drugs
themselves may be discussed in rec.drugs.misc, but their other aspects
should not be. In general, anything belonging in rec.food.drink.* or
alt.smoking.* should not appear here.
HOW TO VOTE
Erase everything above the top "-=-=-=-" line and erase everything
below the bottom "-=-=-=-" line. Do not erase anything between these
lines and do not change the group name. Basically, remove everything
except the ballot - we have to save them all on disk.
Give your name on the line that asks for it. Place a YES or NO in the
brackets next to the group name to vote for or against it. Don't
worry about spacing of the columns or any quote characters (">") that
your reply inserts.
Send MAIL to: voting@Syra.NET
Just Replying should work if you are not reading this on a mailing list.
-=-=-=-=-=- Don't Delete Anything Between These Lines =-=-=-=-=-=-=-=-
rec.drugs Ballot <RD-0001> (Don't remove this marker)
Give your real name here:
If you do not give a real name your vote may be rejected.
[Your Vote] Group
-----------------------------------------------------------------------
[ ] rec.drugs.cannabis
[ ] rec.drugs.psychedelic
[ ] rec.drugs.misc
-=-=-=-=-=- Don't Delete Anything Between These Lines =-=-=-=-=-=-=-=-
Neither ABSTAIN nor CANCEL messages are counted as votes; they serve
only to cancel any previous vote. Abstentions are noted in the final
vote list, whereas CANCEL removes your vote from that list entirely.
(This is the only difference between the two.)
Anything else may be rejected by the automatic vote counting program. The
votetaker will respond to your received ballots with a personal acknowledge-
ment by mail - if you do not receive one within several days, try again.
It's your responsibility to make sure your vote is registered correctly.
If you later change your mind you may vote again; only your last valid
vote will count.
Anonymous votes will not be accepted. Votes mailed by WWW/HTML/CGI
forms are considered anonymous votes. (The vote must be mailed
directly from the voter to the votetaker.)
In cases where voting fraud is determined to have occurred, it is
standard operating procedure to delete ALL votes submitted by the
violator.
If you give anyone a copy of the CFV, it must be whole and unmodified.
When in doubt, ask the votetaker.
Standard Guidelines for voting apply: no more than one vote per person,
no more than one vote per account. If you attempt multiple votes or
other vote fraud, all your votes may be canceled and your name published.
The complete vote list will be posted with the vote result, including
how each person voted. Note that Usenet votes are not done by secret
ballot.
There will then be a five-day period during which the published vote
list may be corrected and any irregularities addressed. The
requirements for group creation are 100 more YES votes than NO votes,
and 2/3 of all counted votes being YES.
DISTRIBUTION
This CFV has been cross-posted to:
alt.drugs, alt.drugs.caffeine, alt.drugs.chemistry,
alt.drugs.culture, alt.drugs.hard, alt.drugs.pot,
alt.drugs.psychedelics, alt.hemp, alt.psychoactives,
talk.politics.drugs, alt.recovery.na
and EMailed to:
The Anarchy List <anarchy-list@cwi.nl>
From warren@syra.net Thu Jun 22 00:21:05 1995
Status: RO
Path: uunet!bounce-back
From: warren@syra.net (Warren Lavallee)
Newsgroups: news.announce.newgroups,news.groups,alt.drugs,alt.drugs.caffeine,alt.drugs.chemistry,alt.drugs.culture,alt.drugs.hard,alt.drugs.pot,alt.drugs.psychedelics,alt.hemp,alt.psychoactives,talk.politics.drugs,alt.recovery.na
Subject: 2nd CFV: rec.drugs.{cannabis,psychedelic,misc}
Supersedes: <rec.drugs-CFV1@uunet.uu.net>
Followup-To: poster
Date: 21 Jun 1995 23:59:50 -0400
Organization: Usenet Volunteer Votetakers
Lines: 329
Sender: tale@uunet.uu.net
Approved: tale@uunet.uu.net
Expires: 30 Jun 1995 00:00:00 GMT
Message-ID: <rec.drugs-CFV2@uunet.uu.net>
References: <3o8lka$san@rodan.UU.NET> <rec.drugs-CFV1@uunet.uu.net>
Reply-To: voting@syra.net
NNTP-Posting-Host: rodan.uu.net
Xref: gs2.UU.NET news.announce.newgroups:7094 news.groups:154866 alt.drugs:143455 alt.drugs.caffeine:7454 alt.drugs.chemistry:4190 alt.drugs.culture:3941 alt.drugs.hard:1838 alt.drugs.pot:20218 alt.drugs.psychedelics:8209 alt.hemp:21010 alt.psychoactives:11286 talk.politics.drugs:42682 alt.recovery.na:1644
LAST CALL FOR VOTES (of 2)
unmoderated group rec.drugs.cannabis
unmoderated group rec.drugs.psychedelic
unmoderated group rec.drugs.misc
Newsgroups line:
rec.drugs.cannabis The drug cannabis (marijuana).
rec.drugs.psychedelic LSD, Ecstasy, magic mushrooms and the like.
rec.drugs.misc Stimulants, sedatives, smart drugs et al.
Votes must be received by 23:59:59 UTC, 29 June 1995.
This vote is being conducted by a neutral third party. For voting
questions only contact Warren Lavallee <warren@Syra.NET>. For
questions about the proposed group contact Jani Poijrvi
<gnosis@brahman.nullnet.fi>.
RATIONALE
~~~~~~~~~
In brief, over the last year alt.drugs.* has become such a chaotic mess
that it is practically unusable, and we believe that the creation of
rec.drugs is the only workable solution. We are thus proposing that the
three most active alt.drugs.* groups, alt.drugs itself, alt.drugs.pot
and alt.drugs.psychedelics be moved over to the rec hierarchy.
rec.drugs is being proposed because the alt.drugs hierarchy is in such a
mess that last year's split has become worse than useless, and there is no
prospect of matters improving while the groups remain within alt.
A bit of history: alt.drugs, created in 1987, is one of the oldest alt
groups. Its traffic has grown steadily; roughly a year ago it reached such
intolerable levels that a number of subgroups were spawned off.
Unfortunately, the groups were created before a consensus was reached about
them, and many of them (such as alt.drugs.pot, which is meaningless to most
people outside the US) were poorly thought out. They were promptly
rmgrouped by the alt.config regulars, but it was decided that creating a
new set of groups would be even worse, so several sets of booster newgroups
were issued, recreating the hierarchy.
Some selected USENET Arbitron May 1995 [Snowhare] statistics:
Group Readers Propagation Messages Crossposting
~~~~~ ~~~~~~~ ~~~~~~~~~~~ ~~~~~~~~ ~~~~~~~~~~~~
alt.drugs 207816 60% 5450 17%
alt.drugs.pot 44346 32% 3682 36%
alt.drugs.caffeine 41157 48% 391 36%
alt.drugs.psychedelics 35071 31% 1793 37%
alt.drugs.chemistry 29854 32% 595 49%
alt.drugs.culture 19709 32% 821 57%
alt.drugs.hard ? < 20% ? > 50%
When alt.drugs was created, newgroups were honoured by every site that
carried the alt hierarchy; its propagation is still very high for an alt
group. In contrast, by the time the alt.drugs subgroups were proposed, alt
had become very large and disorganised, full of frivolous groups. Newgroup
messages are now treated with some skepticism by many admins, and the
alt.drugs subgroups were created in such a messy way that they enjoy
barely half the propagation of their parent group.
alt.drugs.pot and alt.drugs.psychedelics soon started to generate lots of
traffic, but due to the low propagation of the new groups, almost everything
was, and still is, crossposted to the parent group. And of course, the many
people whose sites do not receive the subgroups still keep on posting to
alt.drugs. Other people, in persevering with the hierarchy and declining to
crosspost everything, make matters even worse. The cure was worse than the
problem: anyone interested in cannabis now has to read both alt.drugs _and_
alt.drugs.pot to catch all the cannabis-related traffic, or at least
crosspost their messages to both groups to catch all readers.
In recent months, Tom Servo (a user at Netcom) has repeatedly posted a
guide to sending the control messages needed to create new groups. Sadly,
his guide makes no mention of Usenet naming conventions or the alt.config
discussion process, which has since led to hundreds of useless and/or
illegally named alt groups being created. It is now much harder to get a
useful group created and widely accepted.
This has been the fate of alt.drugs.hard: it was proposed to address a
clear need, but it has been crippled by its abysmal propagation. What's
more, a number of junk groups have been created without any discussion
whatsoever (e.g. alt.drugs.pot.cultivation, alt.hemp.recreational,
alt.hemp.politics), and they serve only to clutter up the hierarchy and
confuse newbies.
It has long been known that alt groups are almost impossible to destroy;
this recent experience shows that they can be equally difficult to create.
Any steps taken to improve matters are doomed to failure unless they are
widely honoured, and alt is in such a state that there is no hope of this
happening unless the entire drugs hierarchy is moved to the big 8.
Furthermore, the proposed drugs groups in the big 8 are likely to have
identical propagation, which will eliminate the biggest current pressure
to crosspost between them.
The proposed groups are being placed in rec because they are specifically
for recreational drugs; placement in soc, talk or misc would lead to a
greater proportion of off-topic posts. A second-level name has been
chosen because drugs cannot justifiably be placed under any existing
category.
RATIONALE FOR THE HIERARCHY STRUCTURE
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The initial set of rec.drugs.* groups will resemble the three most active
alt.drugs.* groups: alt.drugs, alt.drugs.pot and alt.drugs.psychedelics.
Their charters will be mutually exclusive to a large extent; unlike
alt.drugs, rec.drugs.misc will not be a general dumping ground for every
topic. A fair number of people are likely to subscribe to r.d.cannabis
and/or r.d.psychedelic without joining r.d.misc.
The intention is that the three groups will have (1) roughly equal traffic
levels, and (2) very little crossposting.
The recent Arbitron statistics (see above) show that (1) is plausible.
The proportion of the total alt.drugs.* traffic carried by each group,
discounting the effects of crossposting, was:
alt.drugs 42%
alt.drugs.pot 29%
alt.drugs.psychedelics 14%
rec.drugs.cannabis will be identical to alt.drugs.pot, which has about
the right traffic level at the moment.
rec.drugs.misc will be a bit like alt.drugs without the crossposting,
which will reduce its traffic a fair amount.
rec.drugs.psychedelic will cover a number of popular drugs, such as LSD
and MDMA (Ecstasy). As long as the charter makes this clear, the group's
bandwidth will be fairly high.
(2) will depend on how well the group charters are drawn up. r.d.cannabis
is straightforward, but there is no really simple definition of a
psychedelic. Alexander Shulgin, the world's foremost authority in this
field, defines this word as, "pertaining to a change in the normal state of
consciousness, usually with some accompanying changes in the acuity of the
senses." However, a newbie could conceivably argue that this definition
applies equally well to _any_ recreational drug.
I've based the group charters on the directory structure of the drugs
archive at hyperreal.com. If a drug appears in the /drugs/psychedelics
directory, it belongs in rec.drugs.psychedelic. A pre-existing structure
like this will help resolve borderline cases, when a drug could conceivably
fit into either .psychedelic or .misc. As I said above, MDMA and its
relatives will also appear in r.d.psychedelic, in part to balance out the
levels of traffic between the three newsgroups.
The proposed summary lines are rather terse, but are aimed to guide posts
to the right group within the hierarchy. They will obviously be updated if
the groups are split.
The proposed hierarchy is about as small as it can possibly be, and it will
inevitably grow in the near future. Some people will want it to be bigger
now. However, calls for further groups will tend to be speculative at this
point, and it's less trouble to create new subgroups later than to delete
ones that turn out to be unpopular. There will also be fewer teething
problems associated with the move if the hierarchy is small to begin with.
Six months or so after the initial groups' creation, we can take stock of
the rec.drugs hierarchy, and be in a much better position to know which
further groups are needed.
CHARTER
All three groups
~~~~~~~~~~~~~~~~
Attempts to sell or trade controlled substances here are *NOT*
permissible. Remember that the authorities are likely to be watching
these newsgroups.
Political discussion is strongly discouraged. Please do not post it here
unless it's really important. And if you do post or reply to anything of
a political nature here, please make sure you set follow-ups to
talk.politics.drugs.
Because of the way the rec.drugs hierarchy is divided, the scope of each
group, and the topics discussed there, will be broadly similar. The
main distinction between them is that they will be discussing different
classes of drugs.
The groups are intended to divide up the total rec.drugs traffic in a
sensible way; please be sure to post to the correct one. If your site
receives any one of these groups, it should really receive all of them.
rec.drugs.cannabis
~~~~~~~~~~~~~~~~~~
A newsgroup dedicated to the recreational use of cannabis. Possible
topics include: descriptions of effects; comparisons with other drugs;
advice concerning the experience (e.g. what music to listen to);
paraphernalia (e.g. bongs), home-made and commercial; syntheses,
extractions and recipes.
The following topics are of peripheral relevance to this newsgroup. They
may, at a pinch, be discussed here, but should not make up too much of
the newsgroup's traffic.
Medical uses of cannabis: e.g. the treatment of glaucoma and AIDS
wasting syndrome; countering the toxic side-effects of chemotherapy
(cancer-treating drugs). The suitability or otherwise of alternatives to
cannabis.
Industrial uses of the cannabis plant: e.g. paper, cotton, rope;
hydrocarbons for fuel or plastics. Economic and environmental
considerations. Historical and possible future uses.
rec.drugs.psychedelic
~~~~~~~~~~~~~~~~~~~~~
The psychedelics promise to provide a unique insight into the workings
of the human mind. Set and setting are all-important, which explains the
varying success different researchers have had with them. Their current
legal status, and many of the horror stories concerning them, are based
more in politics than in fact. They are reasonably safe if treated with
respect.
Discussion here concerns the following drugs, and anything with a
similar effect (the list is by no means complete):
Psychedelics: LSD, psilocybin, DMT, 2CB.
Plants and fungi: mushrooms, morning glory seeds, cacti.
Dissociatives: PCP, ketamine, dextromethorphan, Jimson weed.
Empathogens: MDMA (Ecstasy), and its close relatives MDA and MDEA.
As a basic rule, if the drug appears in the /drugs/psychedelics or
/drugs/mdma directories at hyperreal.com, it belongs in this group.
Discussion about many aspects of drug culture (e.g. trippy computer
programs, or iconoclasts such as Timothy Leary) will find a natural home
here.
rec.drugs.misc
~~~~~~~~~~~~~~
This group is devoted to drugs which do not have their own subgroup
within rec.drugs. At present, examples of such drugs are:
Opiates
Stimulants (cocaine, amphetamines, methcathinone)
Depressants (barbiturates, benzodiazapines (e.g. Valium))
Inhalants (nitrous oxide)
Nootropics (smart drugs)
Prozac
This list, which is not intended to be complete, will shorten if and when
a separate newsgroup is created for any of these drugs.
However, rec.drugs.misc is *not* a general discussion ground for all
drugs. Discussions about drugs which have their own rec.drugs newsgroup
should not take place here under normal circumstances.
Caffeine, alcohol and tobacco already have their own fora in the
alt.smoking and rec.food.drink hierarchies. The effects of the drugs
themselves may be discussed in rec.drugs.misc, but their other aspects
should not be. In general, anything belonging in rec.food.drink.* or
alt.smoking.* should not appear here.
HOW TO VOTE
Erase everything above the top "-=-=-=-" line and erase everything
below the bottom "-=-=-=-" line. Do not erase anything between these
lines and do not change the group name. Basically, remove everything
except the ballot - we have to save them all on disk.
Give your name on the line that asks for it. Place a YES or NO in the
brackets next to the group name to vote for or against it. Don't
worry about spacing of the columns or any quote characters (">") that
your reply inserts.
Send MAIL to: voting@Syra.NET
Just Replying should work if you are not reading this on a mailing list.
-=-=-=-=-=- Don't Delete Anything Between These Lines =-=-=-=-=-=-=-=-
rec.drugs Ballot <RD-0002> (Don't remove this marker)
Give your real name here:
If you do not give a real name your vote may be rejected.
[Your Vote] Group
-----------------------------------------------------------------------
[ ] rec.drugs.cannabis
[ ] rec.drugs.psychedelic
[ ] rec.drugs.misc
-=-=-=-=-=- Don't Delete Anything Between These Lines =-=-=-=-=-=-=-=-
Neither ABSTAIN nor CANCEL messages are counted as votes; they serve
only to cancel any previous vote. Abstentions are noted in the final
vote list, whereas CANCEL removes your vote from that list entirely.
(This is the only difference between the two.)
Anything else may be rejected by the automatic vote counting program. The
votetaker will respond to your received ballots with a personal acknowledge-
ment by mail - if you do not receive one within several days, try again.
It's your responsibility to make sure your vote is registered correctly.
If you later change your mind you may vote again; only your last valid
vote will count.
Anonymous votes will not be accepted. Votes mailed by WWW/HTML/CGI
forms are considered anonymous votes. (The vote must be mailed
directly from the voter to the votetaker.)
In cases where voting fraud is determined to have occurred, it is
standard operating procedure to delete ALL votes submitted by the
violator.
If you give anyone a copy of the CFV, it must be whole and unmodified.
When in doubt, ask the votetaker.
Standard Guidelines for voting apply: no more than one vote per person,
no more than one vote per account. If you attempt multiple votes or
other vote fraud, all your votes may be canceled and your name published.
The complete vote list will be posted with the vote result, including
how each person voted. Note that Usenet votes are not done by secret
ballot.
There will then be a five-day period during which the published vote
list may be corrected and any irregularities addressed. The
requirements for group creation are 100 more YES votes than NO votes,
and 2/3 of all counted votes being YES.
DISTRIBUTION
This CFV has been cross-posted to:
alt.drugs, alt.drugs.caffeine, alt.drugs.chemistry,
alt.drugs.culture, alt.drugs.hard, alt.drugs.pot,
alt.drugs.psychedelics, alt.hemp, alt.psychoactives,
talk.politics.drugs, alt.recovery.na
and EMailed to:
The Anarchy List <anarchy-list@cwi.nl>
From warren@syra.net Tue Jul 11 13:28:36 1995
Status: RO
Path: uunet!in1.uu.net!bounce-back
From: warren@syra.net (Warren Lavallee)
Newsgroups: news.announce.newgroups,news.groups,alt.drugs,alt.drugs.caffeine,alt.drugs.chemistry,alt.drugs.culture,alt.drugs.hard,alt.drugs.pot,alt.drugs.psychedelics,alt.hemp,alt.psychoactives,talk.politics.drugs,alt.recovery.na
Subject: RESULT: rec.drugs.{cannabis,psychedelic,misc} passes
Followup-To: news.groups
Date: 10 Jul 1995 18:21:56 -0400
Organization: Usenet Volunteer Votetakers
Lines: 792
Sender: tale@uunet.uu.net
Approved: tale@uunet.uu.net
Message-ID: <rec.drugs-RESULT1@uunet.uu.net>
NNTP-Posting-Host: rodan.uu.net
Xref: gs2.UU.NET news.announce.newgroups:7111 news.groups:158580 alt.drugs:145627 alt.drugs.caffeine:7580 alt.drugs.chemistry:4785 alt.drugs.culture:4524 alt.drugs.hard:1904 alt.drugs.pot:21834 alt.drugs.psychedelics:8862 alt.hemp:21870 alt.psychoactives:11586 talk.politics.drugs:44170 alt.recovery.na:1758
RESULT
unmoderated group rec.drugs.cannabis passes 365:93
unmoderated group rec.drugs.psychedelic passes 356:99
unmoderated group rec.drugs.misc passes 362:99
Yes No : 2/3? >100? : Pass? : Group
---- ---- : ---- ----- : ----- : -------------------------------------------
365 93 : Yes Yes : Yes : rec.drugs.cannabis
356 99 : Yes Yes : Yes : rec.drugs.psychedelic
362 99 : Yes Yes : Yes : rec.drugs.misc
12 invalid votes
rec.drugs.cannabis passed on Wed Jun 14 07:24:34 1995
rec.drugs.psychedelic passed on Wed Jun 14 08:06:36 1995
rec.drugs.misc passed on Wed Jun 14 07:15:42 1995
Newsgroups line:
rec.drugs.cannabis The drug cannabis (marijuana).
rec.drugs.psychedelic LSD, Ecstasy, magic mushrooms and the like.
rec.drugs.misc Stimulants, sedatives, smart drugs et al.
This vote was being conducted by a neutral third party. For
voting questions only contact Warren Lavallee <warren@Syra.NET>.
For questions about the proposed group contact Jani Poijrvi
<gnosis@brahman.nullnet.fi>.
INTERESTING FACT
The # of raw votes I received, before duplicates were filtered, and the
121 votes were removed was 666.
CHARTER
Attempts to sell or trade controlled substances here are *NOT*
permissible. Remember that the authorities are likely to be watching
these newsgroups.
Political discussion is strongly discouraged. Please do not post it here
unless it's really important. And if you do post or reply to anything of
a political nature here, please make sure you set follow-ups to
talk.politics.drugs.
Because of the way the rec.drugs hierarchy is divided, the scope of each
group, and the topics discussed there, will be broadly similar. The
main distinction between them is that they will be discussing different
classes of drugs.
The groups are intended to divide up the total rec.drugs traffic in a
sensible way; please be sure to post to the correct one. If your site
receives any one of these groups, it should really receive all of them.
rec.drugs.cannabis
~~~~~~~~~~~~~~~~~~
A newsgroup dedicated to the recreational use of cannabis. Possible
topics include: descriptions of effects; comparisons with other drugs;
advice concerning the experience (e.g. what music to listen to);
paraphernalia (e.g. bongs), home-made and commercial; syntheses,
extractions and recipes.
The following topics are of peripheral relevance to this newsgroup. They
may, at a pinch, be discussed here, but should not make up too much of
the newsgroup's traffic.
Medical uses of cannabis: e.g. the treatment of glaucoma and AIDS
wasting syndrome; countering the toxic side-effects of chemotherapy
(cancer-treating drugs). The suitability or otherwise of alternatives to
cannabis.
Industrial uses of the cannabis plant: e.g. paper, cotton, rope;
hydrocarbons for fuel or plastics. Economic and environmental
considerations. Historical and possible future uses.
rec.drugs.psychedelic
~~~~~~~~~~~~~~~~~~~~~
The psychedelics promise to provide a unique insight into the workings
of the human mind. Set and setting are all-important, which explains the
varying success different researchers have had with them. Their current
legal status, and many of the horror stories concerning them, are based
more in politics than in fact. They are reasonably safe if treated with
respect.
Discussion here concerns the following drugs, and anything with a
similar effect (the list is by no means complete):
Psychedelics: LSD, psilocybin, DMT, 2CB.
Plants and fungi: mushrooms, morning glory seeds, cacti.
Dissociatives: PCP, ketamine, dextromethorphan, Jimson weed.
Empathogens: MDMA (Ecstasy), and its close relatives MDA and MDEA.
As a basic rule, if the drug appears in the /drugs/psychedelics or
/drugs/mdma directories at hyperreal.com, it belongs in this group.
Discussion about many aspects of drug culture (e.g. trippy computer
programs, or iconoclasts such as Timothy Leary) will find a natural home
here.
rec.drugs.misc
~~~~~~~~~~~~~~
This group is devoted to drugs which do not have their own subgroup
within rec.drugs. At present, examples of such drugs are:
Opiates
Stimulants (cocaine, amphetamines, methcathinone)
Depressants (barbiturates, benzodiazapines (e.g. Valium))
Inhalants (nitrous oxide)
Nootropics (smart drugs)
Prozac
This list, which is not intended to be complete, will shorten if and when
a separate newsgroup is created for any of these drugs.
However, rec.drugs.misc is *not* a general discussion ground for all
drugs. Discussions about drugs which have their own rec.drugs newsgroup
should not take place here under normal circumstances.
Caffeine, alcohol and tobacco already have their own fora in the
alt.smoking and rec.food.drink hierarchies. The effects of the drugs
themselves may be discussed in rec.drugs.misc, but their other aspects
should not be. In general, anything belonging in rec.food.drink.* or
alt.smoking.* should not appear here.
[This collection of addresses is (C)1995 by Consultix Computer Services.
Permission is strictly NOT given to use this list or any part thereof to
make a mailing list, or for mass-mailings. Any other use is fine.]
rec.drugs Final Vote Ack
rec.drugs.misc -----+
rec.drugs.psychedelic ----+|
rec.drugs.cannabis ---+||
|||
01trmarsh@bsuvc.bsu.edu Tom Marsh (01trmarsh@bsuvc.bsu.edu) YYY
100451.2370@CompuServe.COM J. Th. Poppinger YYY
926286ki@udcf.gla.ac.uk Sam Kington YYY
A.DUPETIT@OLN.comlink.apc.org Alfredo C. Dupetit YYY
aa100960@dasher.csd.sc.edu Charles F (Rick) Leeper YYY
aaron@chrysopylae.com Aaron R. Priven --Y
abraham@iesd.auc.dk Per Abrahamsen --Y
adam@bronze.lcs.mit.edu Adam Glass YYY
adbryan@onramp.net Alan Bryan YYY
adia@egnatia.ee.auth.gr Alejandros Diamandidis YYY
ads93@aber.ac.uk Adrian Shaw NNN
afabbro@umich.edu Andrew Fabbro YYY
afargnol@spdmail.spd.dsccc.com Al Fargnoli YYY
aharvey@boulder.nist.gov A. Harvey NNN
ahlstran@mgi.com Dave Ahlstrand NNN
ajm1007@cus.cam.ac.uk A.J. Moss YYY
akilgour@thinkage.on.ca Anita Kilgour NNN
alahelma@cc.helsinki.fi Antti Lahelma YYY
alf@epix.net Alf the Poet (Michael Pizolato) YYY
ali@panix.com Dark Phoenix YYY
andrea@dyna Andrea Baroni YYY
Andreas.Neubacher@risc.uni-linz.ac.at Andreas Neubacher YYY
andyl@harlequin.com Andy Latto YYN
anne@alcor.concordia.ca Anne Bennett YYY
anto@capcom.apana.org.au Antony Wuth YYY
ao991@lafn.org Eric Vesbit YYY
arielle@bonkers.taronga.com Stephanie da Silva YYY
arromdee@blaze.cs.jhu.edu Ken Arromdee --N
aryone@pcuf.fi Ari Rotonen YYY
ash@MATH.AMS.ORG Alan Harder YYY
Athame1@aol.com DC Potts NNY
atsaarel@freenet.hut.fi Atte Saarela YYY
bac@netcom.com Brian Court YYY
baillod@eecs.umich.edu Brad Baillod YYY
bainard@prism.nmt.edu Phillip Hume NNN
barry@bluesky.com Barry Smith YYY
baudmax@unix.asb.com THOMAS A. FORDHAM, JR. YYY
bbordona@free.org Bruce Bordonaro YYY
bc4997@Bristol.ac.uk Ben Cambery YYY
beezlbu@shadow.net Robert D. Capasso YYY
beladona@ix.netcom.com Beth Deitch YYY
bengtl@maths.lth.se Bengt Larsson NNN
bgg@connect.com.au Ben Golding <bgg@connect.com.au> YYY
bjv@herbison.com B.J. Herbison YYY
blukoff@u.washington.edu Benjamin Lukoff YYY
BOB.EDWARDS%4207PO@x400gw.msfc.nasa.gov Robert L. Edwards NNN
bob@pixi.com James R. Proffitt NNN
bobw@promind.com Bob Wallace YYY
borek@mda.ca Michael Borek YYY
boud@rempt.xs4all.nl Boudewijn YYY
bouma@cs.purdue.edu Bill Bouma YYY
bouvin@daimi.aau.dk Niels Olof Bouvin NNN
brand@iglou.com Karl Hiller YYY
bretta@indy.net William L. Johnson YYY
Brewtus1@aol.com Jeff Wilks YYY
bryan@Novell.COM Bryan Cardoza NNN
bt26+@andrew.cmu.edu Bartley R. Troyan YYY
bubulle@bubhome.frmug.fr.net Christian Perrier NNN
buff@io.org William Denton YYY
burgess@eagle.natinst.com Jason Burgess YYY
burt+@CMU.EDU Burt Holzman NNN
bvrolyk@linetap.com Brian Vrolyk YYY
by177@cleveland.Freenet.Edu D. L. Mosher YYY
C.R.Gadsden@politics.hull.ac.uk Richard Gadsden YYY
c.w.aude@LaRC.NASA.GOV Carl W. Aude NNN
cadesjar@calum.csclub.uwaterloo.ca Curtis Desjardins YYY
CAD_LANE@pisces.colorado.edu JIM YEKEL YYY
cameroap@acasun.eckerd.edu Andrew Cameron YYY
casioc@orplid.shnet.org Carsten A. Riggelsen (casioc@orplid.shnet.org) YYY
catseye@netcom.com Mark Kupferman YYY
cburian@students.uiuc.edu Christopher Burian YYY
ccm19@columbia.edu C Mclagan YYY
ceej@genmagic.com C J Silverio YYY
cgarnett@amhux3.amherst.edu C. Garnett NNN
chadg@primenet.com Chad Gowin YYY
chris@phil.uni-sb.de Chris Blum YYY
Christian.Kaiser@mch.sni.de Christian Kaiser YYY
chuck@debian.cmhcsys.com Charles A. Stickelman YYY
chucko@rahul.net Chuck Fry YYY
ckk@uchicageo.edu Chris Koenigsberg YYY
claude@muffin.pronet.com Claude YYY
clewis@ferret.ocunix.on.ca C Lewis NNN
clstampe@mailbox.syr.edu Chris Stamper NNN
clsteven@mcs.com Craig L. Stevenson YYN
cml@df.lth.se C Malte Lewan YYY
cmmilum@cotton.vislab.olemiss.edu Jeremy Milum YYY
cmplxgal@ix.netcom.com Robin Miller YYY
conboymj@leland.Stanford.EDU Mike Conboy YYY
conneen@bigwood.EE.CORNELL.EDU Timothy P. "The Dorf" Conneen YYY
costello@muikku.pulp.nullnet.fi Antti Järvinen YYY
coughlen@students.uiuc.edu Steven Coughlen YYY
cr39+@andrew.cmu.edu Christopher B. Reeve YYY
craigs@netcom.com Craig Simmons YYY
crichmon@freenet.columbus.oh.us Christopher Richmond YYY
crouchkp@flidh101.delcoelect.com K. Crouch ---
crowell@theochem.uwaterloo.ca Ken Crowell YYY
CrystlLthr@aol.com Derick Nicholls YYY
csaamw@urc.tue.nl Michiel Wijers NNN
cspot@netcom.com Chris.Hilker YYY
CTHELAN@ese.clemson.edu Christian Thelander YYY
cward@Think.COM Christopher Ward NNN
d3august@dtek.chalmers.se Bj|rn Augustsson YYY
dacosta@prl.philips.nl Paulo da Costa NNN
dan.r@ix.netcom.com Dan Rothschild YYY
daniel@vis.inf.ethz.ch Daniel Gerald Kluge YYY
dark@xs4all.nl Richard Braakman YYY
dave@elxr.jpl.nasa.gov Dave Hayes YYY
davec@wsti.demon.co.uk David Churcher YYY
davek@rahul.net David Kramer YYY
davidm@ozemail.com.au David McDonald YYY
ddb@anubis.network.com David Dyer-Bennet YYY
deepak.brar@macsch.com Deepak Brar YYY
den@po.CWRU.Edu Robert Lee Taylor II YYY
dennis@is.co.za Dennis Goldman YYY
desj@ccr-p.ida.org David desJardins NNN
dfrost@maths.tcd.ie Dermot Frost YYY
dgazoo@MCCSPO.MEDCTR.UCLA.EDU Dana R. Gazoo-Tewalt YYY
dhartung@mcs.com Dan Hartung YYY
djmc100@mailer.york.ac.uk Doug Clow YYY
dnewcomb@whale.st.usm.edu Donald Newcomb NNN
donovan@bnr.ca Marc Donovan YYY
doug@pluto.towson.edu Doug Mcnaught YYY
doug@texel.com Douglas Parvin YYY
dragonsl@scn.org R. Lindberg & E. Winnie NNN
draziw@netcom.com Ryan YYY
DROBERTS@miningt1.csir.co.za D Roberts YYY
DS6537%CMSUVMB.BitNet@pucc.PRINCETON.EDU Don Kingston NNN
dschen@cs.Buffalo.EDU Daniel CHen NNN
dspalme@mke.ab.com Diane Palme YYY
dverbil@PrimeNet.Com David A. Verbil YYY
dw2x+@andrew.cmu.edu Duane T. Williams YYY
eagle@son3.mc.duke.edu Carter Butts YYY
eahu509@ea.oac.uci.edu Adam C. Ebmeier YYY
eaw@hip.atr.co.jp Eric Woudenberg YYY
egarbos@sanders.com Eric Garbos YNN
egon@ugcs.caltech.edu Egon C. Pasztor YYY
eijkhout@math.ucla.edu Victor Eijkhout YYY
eikes@cs.tu-berlin.de Eike Sauer YYY
eivindb@kjemi.unit.no Eivind Bakken YYY
ejk4e@darwin.clas.virginia.edu Edward J. Kilsdonk YYY
elhorbin@students.wisc.edu Eric Horbinski YYY
embransc@hamlet.uncg.edu EM Branscomb NNN
emel@prometheus.hol.gr Diamantidis Athanasios NNN
ennead@student.umass.edu Charles Seaton YYY
ERENSBERGER@delphi.com Erik Rensberger YYY
eric@csd.uwm.edu Rodney Reid YYY
eris@brahman.nullnet.fi Liisa M”tt”nen YYY
ernzer@paranoid.pfalz.de Patrick C. Ernzer YYY
euromrk@primenet.com GIl Dawson YYY
feldman@cs.tulane.edu Damon Feldman YYY
ferram3@rpi.edu Mike Ferrara YYY
fett@u.washington.edu Gus Lopez YYY
firebug@cloud9.net Regis Finley YYY
franke@sed.cs.fsu.edu Jerry Franke NNN
futurist@deltanet.com Ian Koskela YYY
g9126007@mcmail.CIS.McMaster.CA Kelly T. Conlon YYY
gaffie@zeta.org.au Mario Gaffiero YYY
GARBETT@UTKVX.UTCC.UTK.EDU Shawn P. Garbett YYY
gcarr@omega.csuohio.edu George Carr YYY
gedaliah@panix.com Gedaliah Friedenberg NNN
gee@geesys.GUN.de Juergen Geer YYY
Geoff_Langdale@GS10.SP.CS.CMU.EDU Geoff Langdale YYY
gerdw@cougar.vut.edu.au David Gerard YYY
gerry@wendigo.unl.edu Gerry Harbison YYY
gfry@primenet.com George Fry NNN
ggw@wolves.durham.nc.us Gregory G. Woodbury NNN
ghsst6+@pitt.edu Geoffrey Spear YYY
gibbsm@ll.mit.edu Margaret Gibbs NNN
gkj@panix.com Gregory K. Johnson YYY
gnosis@brahman.nullnet.fi Jani Poijärvi YYY
godfrey2@coventry.ac.uk Bill Godfrey ---
gordon@yuki Gordon Engel NNN
grandi@noao.edu Steven Grandi NNN
Greg.Hajek@lambada.oit.unc.edu Greg Hajek YNY
grendel@netaxs.com Michael Handler YYY
groo@netcom.com Kiran Wagle YYY
guenther@cabal.shnet.org Thorsten Günther YYY
guertinp@IRO.UMontreal.CA Paul Guertin YYY
gz7e@nih.gov gregory zirzow --Y
H.Reusch@ieee.org Holger Reusch NNN
hackard@fc.net Andrew Hackard YYY
hayden@krypton.mankato.msus.edu Robert A. Hayden YYY
heckers@freenet.scri.fsu.edu Shawn Hecker YYY
hillholl@netcom.com Hill Holliday YYY
hood@Eng.Sun.COM Mark Hood YYY
hougen@cs.umn.edu Dean F. Hougen YYY
hyeena@brahman.nullnet.fi Juha Hyokki YYY
irina@rempt.xs4all.nl Irina Rempt Y--
Ismo.Peltonen@tower.nullnet.fi Ismo Peltonen Y-Y
iwj10@cus.cam.ac.uk Ian Jackson YYY
jak@cs.brown.edu Jak Kirman YYY
janek@kuai.se Janek Hellqvist NNN
jay@gordian.com Jay Laefer --Y
jbotari@uoguelph.ca Johanna Botari YYY
jcolman@chem.UCSD.EDU Jonah J. Colman YYY
jdfalk@cais.com J.D. Falk YYY
jeff_crummett@ptst.com Jeff Crummett YYY
jepler@herbie.unl.edu Jeff Epler YYY
jesup@scala.scala.com Randell Jesup YYY
jgotts@engin.umich.edu John Gotts YYY
jharlan@husc.harvard.edu Jeff Harlan YYY
jhost@casbah.acns.nwu.edu J Host YYN
JIMSE@Novell.COM Jim Sermersheim YYY
jlaiho@ichaos.nullnet.fi Juha Laiho Y--
jmaynard@admin5.hsc.uth.tmc.edu Jay Maynard NNN
jndmy@cotton.vislab.olemiss.edu Dennis Michael Yates YYY
jnr@cinenet.net Jim Rosenfield YYY
joanna@mail.utexas.edu Joanna L. Castillo NNN
joerg@stehle.augusta.de Joerg Stehle YNN
joha@damicon.fi Johannes Grönvall YYY
John.Atkinson@mail.enterprise.net John Atkinson NNN
JOHN@uhs1.uhs.uga.edu John D. Hopkins NNN
jon@armory.com Jon Shemitz YYY
jon@calweb.com Jonathan Cline YYY
jonas.karlin@cyberland.ct.se Jonas Karlin YYY
jonboy@io.org Trevor Tymchuk YYY
jonivar@festival.ed.ac.uk jon ivar skullerud NNN
joseph@cis.ohio-state.edu Sudish Joseph YYY
jpc@hammer.msfc.nasa.gov J. Porter Clark NNN
jpff@maths.bath.ac.uk John Fitch -NN
jpraino@axalotl.demon.co.uk John Praino YYY
jrm@globalvillag.com John R. MacWilliamson NNN
jroll@squeaky.free.org Jason Rolland YYY
JSCHIESSER@delphi.com Jody Schiesser YYY
jsherman@u.washington.edu Josh Sherman YYY
jsimmons@squeaky.free.org Jonathin Simmons YYY
jsk591@lulu.acns.nwu.edu Joshua Kreitzer NNN
jsty@ozemail.com.au John Styles YYY
julian@bongo.tele.com Julian Macassey NNN
juphoff@tarsier.cv.nrao.edu Jeffrey A. Uphoff YYY
justin@qdeck.com Justin Wilmsmeyer YYY
jyoung@luna.cas.usf.edu Jonathan Young --Y
jyrkis@paju.oulu.fi Jyrki Sarkkinen YYY
Karl.Tombre@loria.fr Karl Tombre NNN
kcci1@central.sussex.ac.uk Alan L.M. Buxey YYY
kenc@oneworld.com Kenneth Corbin YYY
KentuckyJ@aol.com John Holt (kentuckyj@aol.com) YYY
kevinh@lehman.com Kevin Hanrahan YYY
Kian.Spongsveen@sable.npaid.no Kian Spongsveen YYY
killourh@chaph.usc.edu Patrick Killourhy YYY
kingle@cisco.com Kevin Ingle Y--
kooter@cyberspace.com Kooter YYY
kor2@midway.uchicago.edu Pamela Korda YNY
kravietz@pipeta.chemia.pk.edu.pl Pawel Krawczyk YYY
kronin@access.mountain.net Joseph H. Patchell YYY
kwattles@sas.upenn.edu Kirk Wattles YYY
kyousten@bev.net Ken Yousten NNN
lamontg@u.washington.edu Lamont Granquist YYY
lance@rahul.net Lance Chun NNN
lantzr@physio-control.com Lantz Rowland YYY
LAURAHELEN@delphi.com Laura Morgan YYY
Laurent.Challier@inria.fr Laurent Challier YYY
lewis@aera2.mitre.org Keith Lewis YYY
liberty@eskimo.com Michael Justice YYY
list-votes@dream.hb.north.de Martin Schr"oder YYY
LSEAMANS@MU3.MILLERSV.EDU Lynne Seamans NNN
ludwig.b@psycho.org Ludwig Boeckel YYY
luke@smd.smd.sublink.ORG Luciano Mannucci YNY
Lutz.Donnerhacke@Jena.Thur.De Lutz Donnerhacke YYY
lvds@stdin.gatelink.fr.net Peter McNamara YYY
lyssa@unix.tpe.com Lyssa Gold NNN
M.BOBE@BIONIC.zerberus.de Markus Bobe YYY
m91jru@student.tdb.uu.se Jesper Rudberg YYY
mabell@cyberenet.net Jake Hansen YYY
mac7@po.CWRU.Edu Michael A Chary NNN
mactpl@netcom.com Mac Leckrone YYY
malcolm@cs.su.oz.au Malcolm Bjorn Gillies YYY
mamawufu@shore.net Virginia T. McMorran YYY
marc@ALGORITHMICS.COM Marc Moorcroft -N-
marc@world.std.com Marc Dashevsky YYY
mark@lightning.ow.nl Mark Verboom YYY
masstn95@student.umu.se Magnus Stromgren YYY
matt@gazba.demon.co.uk Matt Israelsohn YYY
matt@physics.berkeley.edu Matt Austern YYY
mau@beatles.cselt.stet.it Maurizio Codogno NNN
mckelvey@fafnir.com Jim McKelvey YYY
mcmorran@shore.net Roy A. McMorran YYY
mdimeo@brooktree.com Matt DiMeo YYY
metzemakers@labri.u-bordeaux.fr Timo Metzemakers YYY
mfisch@cscip.uni-sb.de Matthias Fischmann YYY
Michelle.Mader@lerc.nasa.gov Michelle Mader NNN
mike@w3eax.umd.edu Mike Chapman YYY
mikeb@ssd.fsi.com Mike Bates NNN
mjj@netcom.com Michael Johnson YYY
mkc@graphics.cornell.edu Mitch Collinsworth NNN
mlamar@sco.COM Mike 'Lew' Lamar YYY
mmathis@xnet.com Michael A Mathis YYY
mmt@RedBrick.COM M Mike Taksar NN-
mobrien@posgate.apana.org.au Michael O'Brien YYY
mosher@skypoint.com Mosher Man YYY
moss@bastille.cchem.berkeley.edu Dave NNN
mpmNS@fcolcc.hampshire.edu Michelle Murrain YYY
mr@mr.seanet.com Mark Riddell YYY
msattler@jungle.com Michael Sattler YYY
msb@sq.com Mark Brader NNN
msjayn@mars.lerc.nasa.gov Douglas T. Jayne YYY
mwwheatl@telepath.com Mark Wheatley YYY
nahender@plains.nodak.edu Nathanael Henderson YYY
neeri@iis.ee.ethz.ch Matthias Neeracher YYY
net@cs.tu-berlin.de Oliver Laumann YYY
netrin@gti.net Alexandr v Gautama YYY
nhaven1@minerva.cis.yale.edu David Krinsky YYY
nick@inferno.fc.hp.com Nick Ingegneri YYY
nigel@libparty.demon.co.uk Nigel Ashton YYY
nils@sparrowhawk.cs.dartmouth.edu Nils Nieuwejaar YYY
nmehl@near.net Nathan J. Mehl YYY
norman.birkett@gs.com Norman Birkett NNN
nosborne@uhunix.uhcc.Hawaii.Edu Nathaniel Osborne YYY
npatrick@world.std.com Neal Patrick YYY
ocean@usa.pipeline.com Jason Best YYY
Olaf.Laczak@Helsinki.FI Olaf Laczak YYY
olaf@inka.de Olaf Titz YYY
olddog@ix.netcom.com Andrei Foldes YYY
Ollivier.Robert@hsc.fr.net Ollivier Robert YYY
ondler@mhd1.moorhead.msus.edu Eric Ondler YYY
orc@pell.com david parsons YYN
orf@scrap.ssec.wisc.edu Leigh Orf YYY
paasivir@kanto.cc.jyu.fi Risto Paasivirta (paasivir@jyu.fi) -YY
pace@cs.ucdavis.edu James YYY
pardoz@io.com Abd Al-Azrad YYY
patl@skyclad.lcs.mit.edu Patrick J. LoPresti YYY
pceval01@fiu.edu Peter Cevallos YYY
pdecker@lds.loral.com Philip Decker YYY
pe95010@sable.ox.ac.uk Andy Linkin YYY
PEACOCT6503@uni.edu T. Jordan "Greywolf" Peacock NNN
petea@zurich.gcomm.com Pete Amsters YYY
petelev@tivoli.com Peter Steven Levinthal YYY
peter@haywire.DIALix.COM Peter Wemm YYY
peter@petermc.demon.co.uk Peter McDermott YYY
peterc@conch.aa.msen.com Peter Campbell NNN
peterf@fcserver.dol.com Peter Fraterdeus YYY
pflo@unm.edu Pat Florence YYY
philip@storcomp.demon.co.uk Philip Hunt YYY
phillips@bright.uoregon.edu N. Christopher Phillips NNN
phoffman@proper.com Paul E. Hoffman YYY
pimentel@roots.ultranet.com John Pimentel NNN
pjh1@leicester.ac.uk Pete Humble YYY
pjordan@gpu.srv.ualberta.ca Peter Jordan YYY
pk@io.org Peter Klungel YYY
planders@mail.utexas.edu Preston Landers YYY
plutt@mtek.chalmers.se Pelle Johansson YYY
pmelo@mat.uc.pt Paulo Melo YYY
polzer@uran.informatik.uni-bonn.de A. Polzer NNN
poole1@husc.harvard.edu Geoffrey Poole YYY
ppennane@cc.helsinki.fi Petrus Pennanen YYY
ppint@i-m-t.demon.co.uk p. pinto ("ppint.") YYY
press2@cbnews.att.com Barry Olson YYY
price@jove.acs.unt.edu Aaron Price NNY
pspud@peregrin.com Doug Gregory YYY
psyche@brahman.nullnet.fi Sanna Virtanen YYY
ptait@magna.com.au Peter Tait Y--
ptbast@owl.WPI.EDU Pete Bastien --N
pulkkine@mits.mdata.fi Jussi Pulkkinen YYY
pyro@linetap.com James Martin Vrolyk YYY
questor@io.com Michael A. Stoodt YYY
R.HEINRICH@IUS.gun.de Robert Heinrich YYY
radrayer@panix.com Rebecca Drayer NNN
ralph@vara.nl Ralph Moonen YYY
rander@m-net.arbornet.org Ralph Anderson YYY
rando@werple.mira.net.au Brett Paulin YYY
rc@hal.com Rolland Crunk YYY
rew@CrystalData.COM Ryan Waldron NNN
rick@crick.ssctr.bcm.tmc.edu Richard H. Miller NNN
rkatajam@snakemail.hut.fi Riku Katajamaki YYY
rob@analogy.com Robert C Robertson - rob@analogy.com NNN
robert@lawson.win-uk.net Robert G. Lawson YYY
robertg@netcom.com Robert Griedt YYY
robsmith@u.washington.edu Robert P. Smith YYN
roderick@gate.net Roderick Schertler YYY
ronmc@ccnet.com Ron McGuire NNN
ronnie@cisco.com Ronnie B. Kon YYY
russotto@pond.com Matthew T. Russotto YYY
s766184@aix2.uottawa.ca Jake Wadland YYY
sagex003@maroon.tc.umn.edu racer x YYY
sandman@ganet.net Carmen Rocco YYY
sandmann@clio.rice.edu Charles Sandmann NNN
sao@MIT.EDU Steve Oakland YYY
SAYOUNG@glg.ed.ac.uk Stuart Young YYY
scheidell@fdma.fdma.com Michael S. Scheidell NNN
schulz@informatik.tu-muenchen.de Stephan Schulz YYY
schwartz@bach.convex.com Adam Schwartz YYY
scotti@iem.com Scott Isaacson YYY
scriptor@tozzi.muc.de Stephan Schreiber YYY
sean@barre.equinox.gen.nz Sean James YYY
ShariV@aol.com Sharon Vogt NNN
shephard@sfu.ca Gordon Harry Shephard YYY
shfF94@hamp.hampshire.edu Scott Henry Fossel YYY
shields@tembel.org Michael Shields YYY
shimeall@cs.nps.navy.mil Tim Shimeall NNN
shrdlu@willow.sdd.trw.com Lynda L. True NNN
simon@darkmere.midland.co.nz Simon Lyall YYY
simpa@xs4all.nl simon boerboom YYY
simpson@netcom.com Bob Simpson YYY
Singlis@bcde.demon.co.uk Steven Inglis NNN
sos@oz.plymouth.edu Steffan O'Sullivan YYY
spamily@io.org Emily Way YYY
SPB@tntv4.ntrs.com Steve Bonine NNN
sswift@hut.fi Niku Toivola YYY
stainles@bga.com Dwight Brown NNN
stankerr@uiuc.edu Stan Kerr YYY
stannenb@emerald.tufts.edu Saul Tannenbaum YYY
steiners@indirect.com Jason Steiner YYY
stephanh@ix.netcom.com Stephan Heumann YYY
Steve.Barton@Eng.Sun.COM Steve Barton YYY
Strict9@cup.portal.com Charles Chadwick YYY
stu@valinor.mythical.com S Labovitz NNN
stuart@cosc.canterbury.ac.nz STUART YEATES YYY
STYX@amanda.dorsai.org Wil Hao YYY
sunny@bluna.ping.de Mario Teetzen YYY
susanj@netcom.com Susan James YYY
sylvain@netcom.com Nicholas Sylvain NNN
s_auge@ira.uka.de Guenther Augustin Y--
talis@intac.com Talis YYY
taurins@in201.inetnebr.com Agris Taurins NNN
taylorj@gaia.ecs.csus.edu Jon Taylor YYY
tbas@sybase.com Tony Basoglu YYY
tc@mcs.com Thomas Cuny NNN
tetsuo@brahman.nullnet.fi Henrik Tikanvaara YYY
tfl@psp.co.uk Thomas Lee YYY
tgandet@azstarnet.com Thom Gandet YYY
tgm@netcom.com Thomas G. McWilliams NNN
Thomas.Granvold@Eng.Sun.COM Thomas Granvold YYY
thomas@geac.co.nz Thomas Beagle YYY
tines@windsong.demon.co.uk Carl Wilson YYY
tlglenn@cs.arizona.edu Ted Louis Glenn YYY
tms@TIS.COM Thomas M. Swiss YYY
Tobias@doomsday.shnet.org Tobias Gierke YYY
tolot@utolot.toppoint.de Marc Christiansen YYY
tom@mvision.com Tom Ritchford YYY
tomj@jac.enet.dec.com Tom Jaskiewicz NNN
tprodin@cadcam.pms.ford.com Tim Prodin NNN
tra@tpone.telepac.pt Tiago Rodrigues Antao YYY
troq@umich.edu Antonio Roque YYY
tsmith@Kuentos.Guam.NET Thomas E. Smith YYY
TSTMGR@UTKVT1.VET.UTK.EDU John R Lewis NNN
twells@netcom.com Tabor J. Wells YYY
tyr@netcom.com Robert Simmons YYY
udaa018@kcl.ac.uk Steven Layson YYY
Ulf.Moeller@hamburg.netsurf.de Ulf M"oller YYY
una.smith@yale.edu Una Smith YYY
unicorn@Rt66.com S. Huet NNN
urlichs@smurf.noris.de Matthias Urlichs YYY
uspin@mcl.ucsb.edu Stephan C. Barr YYY
V.BURMESTER@CL-HH.comlink.de Volker Burmester YYY
vaf5q@fermi.clas.virginia.edu Virginia Anne Fairchild YYY
vendu@snakemail.hut.fi Tuomo Venalainen YYY
verbeek@HOPE.CIT.HOPE.EDU Todd VerBeek YYY
verdant@student.umass.edu Brian S. Julin (Sol Lightman) YYY
vez@engin.umich.edu Thomas E. Vesbit YYY
vhakulin@cc.helsinki.fi Ville Hakulinen YYY
vinkers@chem.vu.nl vinkers@chem.vu.nl NYY
vishnu@funcom.no Eivind Eklund YYY
vp@fct.unl.pt Vasco Pedro YYY
W.REIS@doo.donut.ruhr.com Werner Reisberger NNN
waal@informatik.uni-bonn.de Christian de Waal YYY
wakelyn@pinn.net Tom Wakelyn NNN
wardk@cse.ogi.edu Karen Ward YYY
wblalok@xmission.com William Blaylock YYY
wdstarr@crl.com William December Starr YYY
widenius@cc.helsinki.fi Risto Widenius NNN
will@dyson.microserve.com Will Dyson YYY
wkwilson@rhic.physics.wayne.edu William Kenneth Wilson YYY
wombat@aquilagroup.com Christopher M. Conway YYY
wsk@netcom.com William Kish YYY
x-dus@brahman.nullnet.fi Mikko Elo YYY
yagelnik@actcom.co.il Yaniv Gelnik YYY
yaje@accessone.com Christopher Lee Wolfe YYY
ylee@columbia.edu Yeechang Lee NNN
zdlh19@sc.msc.edu David L. Hanson NNN
zu02311@uabdpo.dpo.uab.edu Eddie Saunier YYY
Votes in error
------------------------------------------------------------------------------
3rac13@qlink.queensu.ca Chase Ryan A
! No vote statement in message
an216536@anon.penet.fi Dave Roberts
! Invalid address
bruce@mindmedia.com
! No name given
Bruno.Beaufils@lifl.fr
! No name given
geoffl@GS10.SP.CS.CMU.EDU
! No name given
jbmeyer@cats.ucsc.edu
! No name given
manus@telerama.lm.com manus
! No vote statement in message
nipo@brahman.nullnet.fi N. Ipo
! No ballot
phil@pjarrow.demon.co.uk Philip John Arrowsmith
! No vote statement in message
rtfm@cyberspace.com Dan Thies
! No vote statement in message
ultryx@dialup.oar.net Ultryx Corporation
! No vote statement in message
xmcaulif@tyrell.net
! No name given
IRREGUALRITY [notes from vote taker]
Jason Rolland <jroll@squeaky.free.org> sent a note to many people during
the voting period trying to get YES votes on this vote. His message made
if very easy to vote yes, and very hard to vote no. If anyone responded
to his message, quoting it, they ended up voting yes.
I decided to INVALIDATE the 131 valid votes that the message generated.
IMHO it should be as easy to vote yes, as no, and those 131+ people did
not get that chance.
****************************************************************
This action did not change the result of the vote.
****************************************************************
Here is a tally of the invalidated votes:
rec.drugs results - 131 valid votes
Yes No : Group
---- ---- :
121 10 : rec.drugs.cannabis
120 11 : rec.drugs.psychedelic
118 12 : rec.drugs.misc
Here are the voters whose votes were invalidated:
adw7@columbia.edu Aaron D. Wilson
ajd@goldsword.com Al Dudley
alpert@netaxs.com Robert M. Alpert
aml2@leicester.ac.uk Adam Lounds
andy@eng.tridom.com andrew klenzak
aq599@freenet.carleton.ca A. J. Fleming
Asmodeus96@aol.com Kehr Bailey
bbrunob@mindspring.com Greg Scarborough
berson@alpha.fdu.edu VLADIMIR BERSON
bjm10@cornell.edu Bryan J. Maloney
bobyoung@mindspring.com Bob Young
boekhold@gopher M. Boekhold
carlolsen@dsmnet.com Carl E. Olsen
CARL_M1@verifone.com Carl Millholland *Tech Pubs* 3145
cavasin@chronic.convex.com Vince Cavasin
cblazie@access.digex.net Chris Blazie
chaos@freedom.wit.com chiaroscuro
CNB@UWYO.EDU Christopher Nathan Bane (CNB@UWYO.EDU)
comets@io.org Sarah Rosenblatt
CREATOR@IslandNet.com Matt Elrod
CREATOR@IslandNet.com Matt Elrod
csteiner@echolake.vaultbbs.com Craig Steiner
D.Smith@exeter.ac.uk Daryl Smith
d9340213@zeus.usq.edu.au Karen Aherne
daka@aloha.com Mike Braden
dam@dcs.gla.ac.uk Dave Morning
davidh@easynet.co.uk David Harris
davidson@mercury.sfsu.edu Daniel Davidson
david_m@netvision.net.il David Mauas
dcook@physics.utexas.edu David M. Cook
derk@teleport.com Derk Wehler
df1@csd.uwm.edu Doug Forbush
dms6q@uva.pcmail.virginia.edu Dov Michael Szego
dpletche@netcom.com David Pletcher
DSpezi2433@aol.com Dan Speziale
eascott@mtu.edu Erik A. Scott
ed@figlet.demon.co.uk Edward Hignett
efran@telerama.lm.com Daniel Efran
eleusis@netcom.com jeff jenkins
elwin@weeds.xs4all.nl Elwin Oost
erik@weeds.xs4all.nl Erik Tersteeg
escinc@ix.netcom.com Mike Fake
fournese@cadvision.com Electro
g.sikkema@student.utwente.nl Gert Sikkema
gal2@midway.uchicago.edu Jacob Galley
gbaron@sparc.isl.net Gilbert Baron
geenius@Logical.NET Keith Ammann
georgeb@starbase.neosoft.com George Bradley
gjh@galen.med.virginia.edu Galen J. Hekhuis
gl002c@uhura.cc.rochester.edu george lane
goosey@pgh.nauticom.net Kevin Gennuso
green@lark.cc.ukans.edu Laura Green
greg_bradt@msmgate.mrg.uswest.com Greg Bradt
grifter@atc.ameritel.net Josh Hall
gsmarlow@ouray.cudenver.edu G. Scott Marlowe
gsoc07@epas.utoronto.ca Dave Haans
Hagar@horrible.demon.co.uk Alex Bull
hgibbons@hoshi.Colorado.EDU Hugh Gibbons
hneel@xs4all.nl Hans Nelisse
huyle@ugcs.caltech.edu Huy Le
jamesd@echeque.com James A. Donald
jason@primenet.com Jason Wagner
jbrychel@dev3.ctc.edu JJ Brychell
Jim.Kimble@Eng.Sun.COM Jim Kimble Jr.
jkropfre@gpu.srv.ualberta.ca James Kropfreiter
jmb0009@jove.acs.unt.edu Joseph Micah Brunt
jow2@cornell.edu james williams
jrmo@volta.att.com Joe Moore
JSCHALE@american.edu Jeffrey A. Schaler, Ph.D.
jstoiche@mv.us.adobe.com Jim Stoicheff
kai@hba.trumpet.com.au Kai Howells
kenny@sforge.demon.co.uk Kenneth Brunton (kenny@sforge.demon.co.uk)
kirker@ix.netcom.com Jeffrey Kirk
lajoie@eskimo.com Steve La Joie
leo@buffnet.net Leo Wilson
lindsey@hydra.convex.com Norman A. Lindsey
lundo@telerama.lm.com Jason Tsangaris
markha@tartarus.uwa.edu.au Mark Haselden
mcelfrtj@uwyo.edu Travis J. McElfresh
mcx@Cs.Nott.AC.UK Matthew Carlisle
meestes@engr.ucdavis.edu Mick Estes
Milamber@ix.netcom.com Timothy Lee Keryk-Dodson
milt@sgihub.corp.sgi.com Milt Tinkoff
mosher@skypoint.com Mosher Man
mput5@central.sussex.ac.uk Austen Halsey
mward@jove.acs.unt.edu Mike Ward
Neil@dadden.demon.co.uk Neil Hunt
NotAlpha@aol.com Roger Plyer
oconnorm@gusun.acc.georgetown.edu Margaret M. O'Connor
ott@anubis.kbfi.ee Ott Ko"stner
paulwolf@ix.netcom.com Paul Wolf
pdyjmh@unicorn.ccc.nottingham.ac.uk Mazda Hewitt
peacock@cts.com Torrey Peacock
pha@ub4b.eunet.be Philip Arickx
phil@shuv.demon.co.uk Phil Stovell
pmb@paul.spu.edu Phil Brooks
pmcdonal@mcdonaldconsult.com Pete McDonald - pmcdonal@mcdonaldconsult.com
poulosio@netcom.com Michael Poulos
predd@slip.net Renee LaFlamme
preston.crow@dancer.dartmouth.edu Preston Crow
Publius@chop.isca.uiowa.edu Brandon Ray
rbartsch@lynx.dac.neu.edu RJ Bartsch
rfoy@netcom.com Richard Foy
RHERRICK@us.oracle.com Rick Herrick
rich@weeds.xs4all.nl Richard v.d. Horst
robert@lawson.win-uk.net Robert Lawson
roberth@ugcs.caltech.edu Robert Cresswell
roclark2@vt.edu Robert Clark
rtedw1@mdw061.cc.monash.edu.au Russell Edwards
rts@ddi.digital.net Ronald T. Shaw
sborders@nyx10.cs.du.edu Scott Borders
scotte@eskimo.com Scott Eckelman
sdavis@OntheNet.com.au Steve Davis - sdavis@onthenet.com.au
silly@ugcs.caltech.edu Brad Threatt
sinse@acs.bu.edu Miguel Morales
spam@ugcs.caltech.edu Damian Martinez
spduran@ouray.cudenver.edu Sean P. Duran
spliff@ix.netcom.com Larry R. Trask
steiner@best.com Michelle Anne Steiner
thebishop@infinity-online.com Drew Crampsie
tim@debusy.Princeton.EDU Tim Hollebeek
tiwerner@grail.cba.csuohio.edu tim werner
tiwerner@grail.cba.csuohio.edu tim werner
tmoran@iol.ie Tony Moran
treece@vnet.net Todd A. Reece
turpin@ses.com Russell Turpin
u3i01@cc.keele.ac.uk D A Eger
williamh@ix.netcom.com William Adrian Butch House
woodstok@brahms.udel.edu Evan Michael Picard
xmcaulif@tyrell.net Chris Mcauliffe
xopher@ot.com C. Mikolasky
****************************************************************
This action did not change the result of the vote.
****************************************************************
USENET FACT: Lurker
A person who reads/browses newsgroups but does not actively post.